Identification of distinctive interferon gene signatures in different types of myositisIago Pinal‐Fernandez, Andrew L. Mammen, María Casal-Domínguez et al.|Neurology|2019Cited by 225
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1Andrew L. Mammen, James L. Gulley, Sean J. Pittock et al.|Annals of the Rheumatic Diseases|2018Cited by 134
Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody SpecificityIago Pinal‐Fernandez, Andrew L. Mammen, David R. Amici et al.|Arthritis & Rheumatology|2019Cited by 40
Autoantibodies Recognizing Specificity Protein 4 <scp>Co‐occur</scp> With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile MyositisMatthew A. Sherman, Katherine Pak, Iago Pinal‐Fernandez et al.|Arthritis & Rheumatology|2023Cited by 14
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ <scp>Juvenile‐Onset</scp> DermatomyositisMatthew A. Sherman, Qingyuan Yang, Laura Gutierrez‐Alamillo et al.|Arthritis & Rheumatology|2023Cited by 6